The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk

Journal of Pharmacological and Toxicological Methods

Volumn 56, Issue 2, 2007, Pages 234-238

  Dürmüller, Niklaus ^a   Guillaume, Philippe ^a   Lacroix, Pierre ^a   Porsolt, Roger D ^a   Moser, Paul ^a  

^a Porsolt and Partners Pharmacology   (France)

Author keywords

Convulsions; Dog; EEG; Methods; Pentylenetetrazole; Safety pharmacology; Telemetry

Indexed keywords

AMOXICILLIN; DIAZEPAM; PENTETRAZOLE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM; CLONIC SEIZURE; CONTROLLED STUDY; DOG; DRUG SAFETY; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; NONHUMAN; RECORDING; RISK ASSESSMENT; TELEMETRY;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; DIAZEPAM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROENCEPHALOGRAPHY; INFUSIONS, INTRAVENOUS; MALE; PENTYLENETETRAZOLE; RISK ASSESSMENT; SEIZURES; TELEMETRY;

CANIS FAMILIARIS;

EID: 34548494872     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2007.03.006     Document Type: Article

References (14)

1. Berendt M., and Gram L. Epilepsy and seizure classification in 63 dogs: A reappraisal of veterinary epilepsy terminology. Journal of Veterinary Internal Medicine 13 (1999) 14-20
2. Berendt M., Hogenhaven H., Flagstad A., and Dam M. Electroencephalography in dogs with epilepsy: Similarities between humans and canine findings. Acta Neurologica Scandinavica 99 (1999) 276-283
3. Carmo H., Hengstler J.G., de Boer D., Ringel M., Carvalhi F., Fernandes E., et al. Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse. Naunyn-Schmiedeberg's Archives of Pharmacology 369 (2004) 198-205
4. Christrup L.L. Morphine metabolites. Acta Anaesthesiologica Scandinavica 41 (1997) 116-122
5. Dürmüller N., Porsolt R.D., and Scherschlicht R. Vigilance controlled quantified EEG in safety pharmacology. In: Enna S.J., and Williams M. (Eds). Current protocols in pharmacology (unit 10.6) (2000), John Wiley & Sons, Hoboken, New Jersey
6. Lonsdale D., Nylen K., and McIntyre Burnham W. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats. Brain Research 1101 (2006) 110-116
7. Mazarati A.M., Hohmann J.G., Bacon A., Liu H., Sankar R., Steiner R.A., et al. Modulation of hippocampal excitability and seizures by galanin. Journal of Neuroscience 20 (2000) 6276-6281
8. McKillop D., Hutchison M., Partridge E.A., Bushby N., Cooper C.M., Clarkson-Jones J.A., et al. Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man. Xenobiotica 34 (2004) 917-934
9. Pahlman I., Kankaanranta S., and Palmer L. Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog. Interspecies relationship comparing with human pharmacokinetics. Arnzneimittel Forschnung 51 (2001) 134-144
10. Parmentier R., Bricout D., Brousseau E., and Giboulot T. Dog EEG for wake-promotion studies. In: Enna S.J., and Williams M. (Eds). Current protocols in pharmacology (unit 5.43) (2006), John Wiley & Sons, Hoboken, New Jersey
11. Riazi K., Roshanpour M., Rafiei-Tabatabaei N., Homayoun H., Ebrahimi F., and Dehpour A.R. The proconvulsant effect of sildenafil in mice: Role of nitric oxide-cGMP pathway. British Journal of Pharmacology 147 (2006) 935-943
12. Smith D.A., Rasmussen H.S., Stopher D.A., and Walker D.K. Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man. Xenobiotica 22 (1992) 709-719
13. Storm van Leeuwen W., Kamp A., Kok M.L., and Tielen A.M. Relations between behaviour in dogs and electrical activities in various parts of the brain. Progress in Brain Research 22 (1968) 181-194
14. Widman M., Nilsson L.B., Bryske B., and Lundstrom J. Disposition of remoxipride in different species. Species differences in metabolism. Arnzneimittel Forschnung 43 (1993) 287-297